InvestmentMay 27, 2026, 06:07 AM
Rani Therapeutics to Raise $20.0M in Public Offering
AI Summary
Rani Therapeutics Holdings, Inc. entered into a securities purchase agreement with institutional investors to raise approximately $20.0 million in gross proceeds. The offering includes 12,476,637 shares of Class A common stock at $1.07 per share and pre-funded warrants for 6,214,953 shares at $1.0699 per warrant. The closing is expected around May 27, 2026, with placement agents receiving a 6.0% cash fee.
Key Highlights
- Rani Therapeutics expects to raise approximately $20.0 million in gross proceeds.
- The offering includes 12,476,637 shares of Class A common stock.
- Pre-funded warrants to purchase 6,214,953 shares are also part of the offering.
- Class A common stock is priced at $1.07 per share.
- Pre-funded warrants are priced at $1.0699 per warrant.
- Placement agents will receive a cash fee of 6.0% of gross proceeds.
- A 60-day lock-up period applies to directors, officers, and certain stockholders.
Price Impact
More from RANI